CRISPR-based gene therapies are already changing healthcare for things like sickle cell disease. But CRISPR is bigger than just medicine, and it could revolutionize everything from food and agriculture to green energy fuels to...

CRISPR is a powerful gene editing tool, but its uses have been purely scientific until now. In 2023, US and UK drug regulators including the FDA approved Casgevy, a CRISPR/Cas9-based therapy for sickle cell disease and beta-thalassemia....

Has a doctor ever told you that you just have too much blood? Probably not, but there are a handful of conditions where being a little low might be good for you.

Lots of genetic diseases come down to a small change in a single gene, but how do you treat those diseases when the cells involved don’t have any DNA?

Sickle Cell Disease affects 100,00 Americans, and has been pretty well understood for a long time. So, why are there only two drugs available for the condition? Why are so few research dollars allocated to the problem? Well, the answers...

NSF's 2014 Alan T. Waterman Awardee Feng Zhang discusses the work of his research team on the brain. Zhang is an investigator at the McGovern Institute for Brain Research at MIT and a core member of the Broad Institute of MIT and...